Search
for
Sort by
Research 30 of 1000+
- Zinc deficiency is associated with gynecologic cancer recurrence
- Repurposing Kir6/SUR2 Channel Activator Minoxidil to Arrests Growth of Gynecologic Cancers
- 61537 No Increased Risk of Breast or Gynecologic Cancers in Women with 5α-Reductase Inhibitor Exposure for Female Pattern Hair Loss: A Population-Based Propensity Score-Matched Cohort Study
- Miscellaneous Exogenous Hormones and Breast Diseases: A Matter of Concern for the Gynecologist
- The efficacy of scalp cooling in patients receiving chemotherapy for primary gynecologic cancers: a randomized controlled trial
- Impact of COVID-19 on patients receiving chemotherapy for gynecological cancer
- Qualitative and Quantitative Assessment of Taste and Smell Changes in Patients Undergoing Chemotherapy for Breast Cancer or Gynecologic Malignancies
- Scalp cooling therapy for chemotherapy-induced hair loss in Asian patients with breast or gynecological cancers – a tertiary institution experience
- Reply to: a rare case of vulvar skin metastasis of rectal cancer after operation
- Selenium or No Selenium- That Is the Question in Tumor Patients: A New Controversy
- Venous thromboembolism and women's health
- Expression of Concern: Treatment of hirsutism by finasteride and flutamide in women with polycystic ovary syndrome
- Chemotherapy in Gynecologic Malignancy
- The use of minoxidil to attempt to prevent alopecia during chemotherapy for gynecologic malignancies.
- Sacituzumab Tirumotecan Across Gynecologic Malignancies: One Target, Multiple Diseases
- Safety of Antiandrogens for the Treatment of Female Androgenetic Alopecia with Respect to Gynecologic Malignancies
- Case Study: Hereditary Cancer Genetic Testing in Unaffected Patients May Allow for Early Intervention and Aggressive Management
- A focus on important reproductive health care issues – cancer, urinary incontinence and the consequences of pre‐term birth
- Abstracts from the 2024 WDS Forum - virtual option
- Cancer risk in polycystic ovary syndrome patients: Common treatments and future perspectives
- Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review
- Antiandrogenic drugs, a therapeutic option for frontal fibrosing alopecia patients
- Paclitaxel/Platinum combination regimen and alopecia
- History and physical examination of polycystic ovary syndrome: Detecting too much or too little
- Gender-Affirming Hormone Therapy for Transgender Females
- Moving Chemoprevention Forward into the Most Promising Areas of Study
- Abstract P5-11-11: A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA)
- A phase I safety study of topical calcitriol (BPM 31543) for the prevention of chemotherapy-induced alopecia (CIA).
- A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA): Final study results
- Sex Hormones and Related Compounds, Including Hormonal Contraceptives